nature methods onLine methods Protocol availability. A detailed step-by-step instruction for CLIR-MS/MS is provided as a Supplementary Protocol and is accessible from Nature Protocol Exchange 26 .
synthesis is restricted to short RNAs; 18 O-labeled phosphates can detach; and the small mass shift overlaps with natural isotope patterns, complicating data analysis. Here we introduce CLIR-MS/MS as a broadly applicable approach that precisely identifies the RNA interface of an RBP and its localization on the target RNA at a resolution sufficient to support three-dimensional modeling of RNPs.
We first applied our method to the 85-kDa complex of polypyrimidine tract binding protein 1 (PTBP1) with a natural RNA target. PTBP1 is a key alternative splicing factor and a major internal ribosomal entry site (IRES) trans-acting factor of several cellular and viral mRNAs 8, 9 . This 58-kDa RBP contains four RNA recognition motifs (RRM), whose structures in complex with a small single-stranded CUCUCU motif were determined by nuclear magnetic resonance (NMR) spectroscopy 10 and revealed base-specific recognition of CU or UC dinucleotides by each RRM. However, the recognition of guanines 11 by PTBP1 and cooperative binding of all four RRMs to a large and structured RNA remain unexplained. We used MS and NMR spectroscopy to study PTBP1 in complex with a structured RNA molecule (88 nt) consisting of domains D-F of the IRES of encephalomyocarditis virus (EMCV; referred to as EMCV DElinkF , as it includes domains D, E, the linker E-F and domain F; other RNA constructs are named similarly). This IRES part binds all four RRMs of PTBP1 ( Fig. 1a) and is essential for the regulatory function of PTBP1 in translation initiation 12, 13 .
To precisely determine the binding interface by MS, we UVcrosslinked a PTBP1-EMCV DElinkF complex containing equimolar ratios of unlabeled and fully 13 C 15 N-labeled RNA. Protein-RNA crosslinks appear in the precursor ion mass spectrum as doublets separated by a mass shift that corresponds to the attached, differentially labeled nucleotide(s) (for example, 11 Da for uracil; Fig. 1b and Supplementary Table 1 ). Modified peptides and the modifications themselves are unambiguously identified by the software xQuest 14 , which uses the isotope labeling information to reduce false positive assignments and to improve the identification process (Supplementary Note 1) . MS/MS reveals the sequence of the crosslinked peptide, the modification site and the composition of the nucleotide adduct ( Fig. 1c) . Because long RNA adducts complicate peptide sequencing owing to unfavorable fragmentation properties 4 , we treated the crosslinked RNP with a specific protease (trypsin) and nonspecific nucleases to generate peptides with short nucleotide chains as adducts. Peptide-nucleotide adducts were enriched before LC-MS/MS analysis (Online Methods and Supplementary Note 2).
We identified 22 U-and UU-modified amino acids representing 12 different peptides that belong to all four PTBP1 RRMs structural modeling of protein-rna complexes using crosslinking of segmentally isotopelabeled rna and ms/ms
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ribonucleoproteins (rnPs) are key regulators of cellular function. We established an efficient approach, crosslinking of segmentally isotope-labeled rna and tandem mass spectrometry (cLir-ms/ms), to localize protein-rna interactions simultaneously at amino acid and nucleotide resolution. the approach was tested on polypyrimidine tract binding protein 1 and u1 small nuclear rnP. our method provides distance restraints to support integrative atomic-scale structural modeling and to gain mechanistic insights into rnPregulated processes.
RNPs regulate crucial cellular functions such as gene expression, and even single nucleotide mutations can alter RNA-protein interactions with fatal consequences 1 . Similarly, single amino acid mutations in RNA-binding proteins (RBPs; for example, SRSF2) are sufficient to change binding specificity and cause disease (for example, myelodysplasia 2 ). Deciphering protein-RNA interactions at single amino acid and nucleotide resolution would therefore enable further functional characterization of RNPs and would support integrated modeling, similarly to how data from mass spectrometric (MS) analysis of chemically crosslinked proteinprotein complexes is applied 3 . Photo-crosslinking and liquid chromatography with tandem MS (LC-MS/MS) analysis have been used to identify RBPs bound to a specific subset of RNAs, but the exact positions of the proteins on the RNA have remained inaccessible [4] [5] [6] . Recently, Lelyveld et al. 7 specifically masslabeled single uridines with 18 O in a synthetic 25-nucleotide (nt) let7-pre-microRNA stem-loop to demonstrate, by MS/MS, that U11 and not U12 crosslinks to the processing inhibitor Lin28A. However, this approach is limited, as chemical RNA (Supplementary Table 2 ). Nineteen modification sites were found in close proximity (within 5 Å) to the RNA according to previously reported structures of the individual RRMs 10 ; three modified residues correspond to a region that was affected upon binding of a long single-stranded RNA to RRM34 (ref. 15 ). Non-irradiated control samples exhibited considerably fewer peaks in the ion chromatogram and no detectable nucleotide adducts (Fig. 1d) . The multitude of UU dinucleotides in EMCV DElinkF rendered the localization of the RRMs on the RNA impossible. However, the same analysis conducted on a smaller complex consisting only of RRM1 and the shorter sequence of EMCV E led to a unique localization of the domain to nucleotides 324-326 of the loop (Supplementary Fig. 1) .
To reduce the mapping possibilities for the full-length PTBP1 in complex with EMCV DElinkF , we combined the use of heavy isotopes for MS 3, [16] [17] [18] [19] with the established method of segmental labeling of RNA 20 . We prepared four segmentally isotope-labeled EMCV DElinkF . Each RNA contained either stem-loop (SL) D (called hereafter D), SLE (E), the linker (Link) or SLF (F) in 13 C 15 N-labeled form, while the other parts of the RNA remained unlabeled ( Fig. 1a, Supplementary Fig. 2 and Supplementary Note 3). These RNAs were then mixed with equimolar amounts of fully unlabeled RNA, complexed with PTBP1, UV-crosslinked, enriched and analyzed by LC-MS/MS ( Fig. 1e , Online Methods and Supplementary Protocol). With this procedure, crosslinks detected by their split isotope patterns in the precursor ion spectrum can only reside in the segmentally isotope-labeled part.
We extracted semiquantitative information from the MS data by spectral counting 21 . RRM2 and RRM4 crosslinked exclusively to F and Link, respectively, and RRM1 and RRM3 crosslinked preferentially to E and D, respectively (Supplementary Note 4). We reproduced the results for D in an independent experiment Table 2 ). Tyr127 (RRM1), Tyr267 (RRM2), His411 (RRM3) and His457 (RRM4) were the most frequent modification sites ( Fig. 2a and Supplementary Table 2 ). Based on all detectable di-and trinucleotide modifications, we were able to precisely map RRM3 to nucleotides 5′-U 303 U 304 -3′ of SLD and RRM4 to 5′-U 341 UCC 344 -3′ of the linker E-F ( Fig. 2b and Supplementary Note 5). Contrary to a previous low-resolution model 12 , our data suggest that RRM1 binds to 5′-G 323 UUUGU 328 -3′ of SLE and RRM2 to 5′-C 358 UUUUG 363 -3′ of SLF, which we confirmed independently by NMR experiments. Isolated RRM1 and RRM2 can both bind EMCV E and EMCV F ( Supplementary  Fig. 3 ) but, in the presence of both RRMs, RRM2 occupies the loop of EMCV F (Supplementary Fig. 4) as indicated by the overlapping chemical shifts. When superimposing the NMR spectra of RRM1-EMCV E , RRM2-EMCV F and RRM34-EMCV DElink , we were able to reproduce the spectra of full-length PTBP1 in complex with EMCV DElinkF ( 1 H-13 C heteronuclear multiple quantum coherence (HMQC) with isoleucine, leucine and valine methyl group labeling and 1 H-15 N transverse relaxation optimized spectroscopy; see Fig. 2c and Supplementary Fig. 5 ), demonstrating identical binding of the RRMs in the subcomplexes. Lastly, adding RRM1 to RRM34-EMCV DElink left the signals of RRM34 unchanged while those of RRM1 corresponded to the RRM1-EMCV E complex ( Supplementary Fig. 6 ).
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Taking advantage of the ability of CLIR-MS/MS for highresolution protein-RNA interaction mapping, we used the identified crosslinks as intermolecular distance restraints for structural modeling, combined with restraints derived from available structural data of PTBP1-RRMs 10 (pdb: 2N3O for RRM1) and from RNA structure predictions ( Supplementary Fig. 7 , Supplementary  Tables 3 and 4 and Supplementary Note 5). Notably, all except one (Ile128-AU) CLIR-MS/MS distance restraints were fulfilled by a single conformation for each RRM ( Supplementary  Fig. 8 ; coordinates are provided in Supplementary Data 1-4) with RRM1, RRM2, RRM3 and RRM4 recognizing G 329 UC 331 , C 358 UUU 361 , U 302 UG 304 and C 343 C 344 of EMCV DElinkF , respectively ( Supplementary Fig. 9 ). The previously unreported recognition of a G in syn conformation instead of C by RRM1 is the only possibility that is in agreement with the detected UU adducts on Tyr127. Recognition of G by PTBP1 had been suggested previously 11 , and earlier work 22 on SRSF2-RRM showed that a syn G can effectively replace an anti C with almost identical interactions. The accommodation of a U instead of a C by RRM3 is based on direct experimental evidence (see Supplementary Note 5). These binding registers indicate that the secondary structure context influences the location of the RRMs because CU motifs reside in close proximity within SLD and SLE. Independently, we determined a high-resolution model of the RRM2-EMCV F complex using classical NMR structure determination (coordinates in Supplementary  Data 5) . Notably, the binding register found in the two models is the same (Supplementary Figs. 9 and 10) , demonstrating the high precision and accuracy of CLIR-MS/MS based modeling.
RRM1-EMCV
To demonstrate the applicability of CLIR-MS/MS to larger RNPs, we reconstituted U1 small nuclear RNP (U1snRNP) with either SL12 or SL34 segmentally isotope labeled (Fig. 3a) . U1snRNP consists of a structured RNA bound by ten proteins and initiates splicing by recognizing the 5′ splice site of a premessenger RNA 23 . We detected crosslinks with the zinc finger of SNRPC (also known as U1-C), with the RRMs of SNRPA and SNRP70 (also known as U1-A and U1-70K, respectively) and with SNRPD2 and SNRPG (also known as Sm-D2 and Sm-G, respectively) that are all compatible with previously published structures 24, 25 (Fig. 3b) .
In summary, CLIR-MS/MS revealed the precise structural arrangement of PTBP1 with one of its natural RNA targets, the exact binding registers of its RRMs and the recognition of single stranded guanine-containing pyrimidine tracts embedded in stem-loops. CLIR-MS/MS reports on direct contacts and provides valuable intermolecular restraints for integrated structural biology. It requires no chemical modifications and thus minimizes the risk of artifacts. This approach is not restricted to RRM-containing proteins and is not limited by size, solubility or crystallizability, although crosslinking efficiency can vary among complexes and improvements in experimental and computational procedures will likely be required for highly complex samples (Supplementary Note 6) . Thus, it is applicable to any RNP of interest for elucidating protein-RNA interactions and generating and refining precise structural models of such RNPs. We expect the method will be applicable to more complex systems such as in vitro reconstituted multicomponent RNPs.
methods
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
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RNA in vitro transcription and purification. Large RNAs such as EMCV DElinkF (nucleotides 287-371, 5′-GGAUACUGGC CGAAG CCGCUUGGAAUAAGGCCGGUGUGCGUUUGUCUAUA UGUUAUUUUCCACCAUAUUGCCGUCUUUUGGCAAUG UG-3′), EMCV DElink (nucleotides 287-346, 5′-GGAUACUGGC CGA AGCCGCU UGGAAUAAGG CCGGUGUGCG UUUGUCUAUA UGUUAUUUUCCAC-3′), HH-U1-SL12 (5′-gggaucagguaagua uccugaaguauccugaugaguccgugaggacgaaacgguacccggua ccgucGAUACUUAC CUGCAGGGGAGAUAC CAUGAU CACGAAGGUGGUUUUCCCAGGGCGAGGCUUAUCCAUU GCACUCCGGAUGUGCUGACCCCUGCGAUUUCCCGUCG A-3′),U1-SL34(5′-GGGAUCGCUGACCCCUGC GAUUUCCC CAAAUGUGGGAAACUCGAC UGCAUAAUUUGUGGUAG UGGGGGACUGCGUUCGCGCUUUC CCCU-3′) and HH-U1 (5′-gggaucaggu aaguauccug aaguauccug augaguccgu gaggacgaaa cgguacccgg uaccgucGAUACUUACCUGGCAGGGGAGAU ACCAUGAUCA CGAAGGUGGUUUUCCCAGGGCGAGGCU UAU CCAUUGCACU CCGGAUGUGC UGACCCCUGC GAUU UCCCCA AAUGUGGGAA ACUCGACUGC AUAAUUUGUG GUAGUGGGGG ACUGCGUUCG CGCUUUCCCC UGUCGA -3′) were transcribed from linearized plasmids and all other RNA sequences-, namely, EMCV EmutF (5′-GAGCG UUUGUCUAUA UGUgaaaaaggagCAUAUUG CCGUCUUUUG GCAAUGUG-3′), EMCV E (5′-GGAGCG UUUGUCUAUA UGUUCC-3′) and EMCV F (5′-GGAUAUUG CCGUCUUUUG GCAAUGUCC-3′)from short DNA templates (Microsynth). We used T7 RNA polymerase and unlabeled (Applichem) or 13 C 15 N-labeled nucleotide triphosphates (NTPs, produced in-house) 30 for transcription. MgCl 2 concentrations were optimized in 50 µL test reactions for each construct. All transcribed EMCV-derived RNA contained an artificial 5′-GGA or 5′-GAG sequence to enhance transcription initiation. HH-U1 and HH-U1-SL12 contained a hammerhead ribozyme (shown above in small letters) at the 5′ end that was cotranscriptionally cleaved. Names of secondary structure elements of EMCV-IRES constructs correspond to the nomenclature in Kaminski et al. 31 , their nucleotide numbers to Duke et al. 32 . Transcripts were purified by denaturing anion exchange chromatography followed by butanol extraction as described 33 . RNA pellets were resuspended in boiling water, incubated at 98 °C for 1 min and snap-cooled in liquid nitrogen for refolding. EMCV DElinkF and EMCV DElink , which exceed the size range of optimal resolution of the denaturing anion exchange chromatography, were further purified by SEC (HiLoad 16/60 Superdex 200 pg, GE) performed with NMR buffer or 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 (RNase H buffer) as eluent. Purity of all transcripts was tested by urea-PAGE 34 .
Segmental labeling of RNA. We performed RNase H cleavage and DNA-splinted RNA ligation as described by Duss and Diarra dit Konte et al. 20 and to cleave U1-SL12 and U1-SL34 after nucleotides 92 and 16 (both chimSL23: 5′-G m A m A m A m U m C m G m dC dA dG dG G m G m U m C m A m G m C m -3′), respectively, to generate fragments for RNA ligation. Optimal RNA:chimera ratios for cleavage were 50:1 (chimSLE, chimLinkF), 5:1 (chimSLD) and 2:1 (chimSL23) as tested in 15-µL small-scale reactions. Optimal RNase H concentration did not scale up linearly, and large scale cleavage was performed in aliquots of 33 µM RNA and 100 nM RNase H in 750 µL RNase H buffer and the above-mentioned RNA:chimera ratios. 13 C 15 N-labeled EMCV DElinkF RNA was triple-digested with all three chimeras at the same time to produce the isotope-labeled fragments embedding nucleotides 284-319, 320-336, 337-347 and 348-372, corresponding to stem-loop (SL) D, SLE, the linker between SLE and SLF (Link), and SLF, respectively. Cleavage efficiency reached almost 100% for all digests after 2 h at 37 °C, and cleaved products were purified by denaturing anion exchange chromatography followed by butanol extraction 33 .
Fragments for segmental isotope labeling ( Figs. 1 and 3  and Supplementary Fig. 3 ) were annealed to a DNA splint that was reverse complementary to nucleotides 305-361 of EMCV DElinkF (RNA:splint ratio 1:1.2) or nucleotides 69-119 of U1-snRNA. We ligated 10 µM RNA in T4 DNA ligase buffer, 10% PEG 4000 at 37 °C for either 6 h using 500 U/mL of T4 DNA ligase (Fermentas, Weiss units) or 3 h using 0.24 mg/mL T4 DNA ligase produced in-house. After ligation, we digested the EMCV-DNA-splint for 15 min at 37 °C by adding RNase-free DNase I and RDD-buffer (RNase-free DNase Set, Qiagen) to a final concentration of 10 U/mL (Kunitz units). Ligation products were purified using denaturing anion-exchange chromatography followed by butanol extraction and refolding. All steps were monitored using urea-PAGE 34 .
RNA-protein complex formation. Complexes of single PTBP1-RRMs and of PTBP1-RRM12 with their cognate RNA were prepared by mixing both components in equimolar ratios at desired concentrations. To reduce aggregation upon complex formation of PTBP1-RRM34 and PTBP1 with multivalent RNA targets, we mixed appropriate volumes of concentrated protein (0.5-1 mM) rapidly with dilute (5-10 µM), ice-cold RNA. Samples for NMR were further concentrated and purified by SEC using NMR buffer as the running buffer. Fractions were tested by native gel electrophoresis, pooled and concentrated. PTBP1-EMCV DElinkF complexes for UV-crosslinking were made of equimolar mixtures of unlabeled and segmentally or uniformly isotope-labeled RNA. Samples were named D, E, Link and F according to the isotope-labeled RNA segment or U for uniformly labeled RNA. For crosslinking of RRM1, we mixed unlabeled and uniformly isotope-labeled EMCV E at equimolar ratios and added purified RRM1. U1snRNP was prepared as described previously 25 after annealing of the 5′ splice site (5′-GGAGUAAGUCU-3′) of SMN1 exon 7.
UV-induced RNA-protein crosslinking. We irradiated one half of each PTBP1-EMCV DElinkF sample, corresponding to 500 µg for sample U or 250 µg for D, E, Link and F samples, at a concentration of 0.8-1.0 mg/mL using a UV Stratalinker 1800 (Stratagene). The other half of each sample was kept as a control. For U1snRNP, we irradiated 180 µg of U1snRNP 12 and U1snRNP 34 with a concentration of 0.6 mg/mL in 10 mM sodium phosphate, pH 6.8, 50 mM NaCl, 5 mM DTT. For UV treatment, we loaded 50 µL sample per well on a 96-well plate (PS, U-bottom, non-binding, clear; Greiner Bio One), placed it on ice into the UV device with a distance of the sample from the bottom of the device of 12 cm, and irradiated five times with 800 mJ/cm 2 as monitored by the build-in detector. Each irradiation step was separated by 1 min for sample cooling. Irradiated and control samples were precipitated with ethanol as described previously 35 . We optimized the irradiation energy in steps of 800 mJ/cm 2 in the range of 2,400-7,200 mJ/cm 2 total energy on PTBP1-EMCV DElinkF complex using free EMCV DElinkF and free PTBP1 and non-irradiated samples as control.
Digestion, clean up and enrichment of RNA-protein crosslinks.
Ethanol precipitates were resuspended and hydrolyzed according to Sharma et al. 35 . In brief, pellets were resuspended in 50 µL 50 mM Tris-HCl, pH 7.9, 4 M urea; diluted with 150 µL 50 mM Tris-HCl, pH 7.9, to a urea concentration of 1 M; and incubated at 52 °C after addition of 1.25 U RNase T1 (ThermoFisher) and 1.25 µg RNase A (Ambion), which corresponds to 5 U and 5 µg enzyme per milligram of RNA-protein complex, respectively. After 2 h, samples were cooled on ice, supplemented with MgCl 2 to a concentration of 1 mM and digested with 31.25 U benzonase (Sigma-Aldrich; 125 U per milligram complex) at 37 °C for 1.5 h. After RNA digestion, we added 7 µg trypsin (Promega), yielding a 24:1 protein:enzyme ratio (w/w), and incubated the samples overnight on a thermomixer (Eppendorf) at 650 r.p.m. and 37 °C, inactivated trypsin for 10 min at 70 °C, replenished 25 U benzonase, 1 U RNase T1 and 1 µg RNase A, and completed the RNA digestion for 1 h at 37 °C. Digestions were purified by solid-phase extraction (SPE, Waters SepPak tC18 cartridges) and RNA-protein crosslinks were enriched by titanium dioxide affinity chromatography according to Leitner et al. 36 . SPE eluates were dried and resuspended in 100 µL of 50% acetonitrile, 0.1% trifluoroacetic acid, 300 mM lactic acid. The samples were then incubated with 5 mg of pre-equilibrated TiO 2 beads (5 µm Titansphere, GL Sciences). We used the same buffer for equilibration, incubation and the first washing step. A second washing step was performed with 50% acetonitrile, 0.1% trifluoroacetic acid, followed by elution with 50 mM ammonium phosphate, pH 10.5. For each step, we incubated the beads for 10 min at 1,400 rpm on a mixer and pelleted them by centrifugation at 16,100g for 2 min. All eluates were immediately acidified to pH 2 with concentrated TFA and purified by SPE as above.
LC-MS/MS and MS-data-analysis.
For mass spectrometry analysis, samples were resuspended in 16 µL of water/acetonitrile/formic acid (95:5:0.1, v/v/v), and 4 µL of each sample were used for duplicate injections. LC-MS/MS analysis was performed with an Easy nLC 1000 HPLC system (ThermoFisher Scientific) connected to an Orbitrap Elite mass spectrometer (ThermoFisher Scientific) equipped with a Nanoflex electrospray source. For the PTBP1 samples, peptides were separated on a PepMap RSLC column (150 mm × 75 µm, 2 µm particle size, ThermoFisher Scientific) using a gradient of 5 to 30% mobile phase B across 60 min, where A is water/acetonitrile/formic acid (98:2:0.15, v/v/v) and B is acetonitrile/water/formic acid (98:2:0.15, v/v/v); the flow rate
